TN2011000012A1 - Sphingosine 1 phosphate receptor modulateors and their use to treat muscle inflammation - Google Patents

Sphingosine 1 phosphate receptor modulateors and their use to treat muscle inflammation

Info

Publication number
TN2011000012A1
TN2011000012A1 TN2011000012A TN2011000012A TN2011000012A1 TN 2011000012 A1 TN2011000012 A1 TN 2011000012A1 TN 2011000012 A TN2011000012 A TN 2011000012A TN 2011000012 A TN2011000012 A TN 2011000012A TN 2011000012 A1 TN2011000012 A1 TN 2011000012A1
Authority
TN
Tunisia
Prior art keywords
modulateors
sphingosine
phosphate receptor
muscle inflammation
treat muscle
Prior art date
Application number
TN2011000012A
Other languages
French (fr)
Inventor
Timothy Wright
Peter Gergely
Syed Sohail Ahmed
Marco Londei
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/059440 external-priority patent/WO2010010127A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2011000012A1 publication Critical patent/TN2011000012A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The use of an S1P receptor modulator of the formula (Ia) or (Ib) wherein the meaning of the different residues is that indicated in claim 1, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
TN2011000012A 2009-07-22 2011-01-13 Sphingosine 1 phosphate receptor modulateors and their use to treat muscle inflammation TN2011000012A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/059440 WO2010010127A1 (en) 2008-07-23 2009-07-22 Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation

Publications (1)

Publication Number Publication Date
TN2011000012A1 true TN2011000012A1 (en) 2012-09-05

Family

ID=55024325

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000012A TN2011000012A1 (en) 2009-07-22 2011-01-13 Sphingosine 1 phosphate receptor modulateors and their use to treat muscle inflammation

Country Status (1)

Country Link
TN (1) TN2011000012A1 (en)

Similar Documents

Publication Publication Date Title
EP2695615A3 (en) Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
MX341212B (en) Benzodiazepine bromodomain inhibitor.
EP3195868A3 (en) Therapeutic use of a tlr agonist and combination therapy
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
MY168791A (en) Carbamate compounds and of making and using same
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
MX2014000130A (en) Methods and compositions for inhibition of bone resorption.
NZ598489A (en) Combination therapy for treating proliferative diseases
CO6410279A2 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
BR112012018256A8 (en) Parkinson's disease treatment method
SG178948A1 (en) Fatty acid niacin conjugates and their uses
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
NZ593688A (en) Micrornas that regulate muscle cell proliferation and differentiation
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
MX337614B (en) Treatment of lupus nephritis using laquinimod.
MY173215A (en) Acetylcysteine compositions and methods of use thereof
BR112014015482A8 (en) phenyl carbamate compounds for use in the alleviation or treatment of pain and neuropathic pain
MX2009004017A (en) The uses of the carboxy-amido-triazole compounds and salts thereof.
WO2014130691A3 (en) Pharmaceutical formulations of nitrite and uses thereof
MX2012002681A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units.
IN2012DN03428A (en)
BR112012027092A2 (en) methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
MX2013008175A (en) Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof.
MX2013006319A (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer.
TN2011000012A1 (en) Sphingosine 1 phosphate receptor modulateors and their use to treat muscle inflammation